NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/30/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization93.41 mln
Float135 mln
Earnings Date08/10/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.43
Borderline
1-Year Forecast
2.00
Transformational upside
Relative Strength
88
/ 100
Strongly outperforming
Debt / Equity
15.50
Extremely leveraged
Dividend Yield
0.00%
No dividend
Business Description
Heron Therapeutics is a North Carolina-based biotech company focused on improving patient care through innovative drug delivery. Its core technology allows a single dose of medication to remain active in the body for days or even weeks, reducing how often patients need treatment. The company sells several approved products that help cancer patients manage nausea and vomiting caused by chemotherapy, and it is also developing a local anesthetic designed to provide longer-lasting pain relief after surgery.
